FY2026 Appropriations. Defense - Prostate Cancer Research Program; L-HHS - Prostate Cancer Activities, Division of Cancer Prevention and Control at the CDC, National Cancer Institute, National Institutes of Health
2025 · 3rd Quarter (July 1 - Sep 30)
ZERO PROSTATE CANCER
Filed by ZERO PROSTATE CANCER.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 14, 2025
- Income
- Not reported
- Expenses
- $130,000.00
- Registrant
- ZERO PROSTATE CANCER
- Client
- ZERO PROSTATE CANCER
- Filing UUID
- 82568bf8-d777-4d3a-b125-9b60d03700da
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening
HR 1300/S 293 PSA Screening for HIM Act - eliminating cost sharing for prostate cancer screening, extension of enhanced Advance Premium Tax Credits for Marketplace plans
VA Precision Oncology Program for Cancer of the Prostate
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.